Testing effectiveness (Phase 2)Looking for participantsNCT04838041
What this trial is testing
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia
Medical College of Wisconsin 51